Sustained Release with Topical Administration DelSiTech’s Silica Eye Drop formulation is designed to provide up to 24-hour controlled release of the drug in the tear fluid with once-daily application. Key benefits include: - once-a-day dosing - support for sustained drug levels for up to 24 hours - stabilisation of the drug - supports steady-state dosing with minimal fluctuation - has shown potential to maintain therapeutic drug levels even overnight - comfortable application and well tolerated in Phase 1 clinical studies These eye drops offer a promising approach to non-invasive ocular therapy, addressing common limitations of conventional topical drops such as poor bioavailability, rapid drainage, and low patient compliance.
